POCI · Precision Optics Corporation, Inc. · Financials

$4.41 -0.06 (-1.23%)

Market Cap

$50.67M

10.97M

Volume · Oct 5 21.76K Avg daily vol (3M) 52.34K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$31.53M +65.2%

FY2026

Net Income

-$3.63M +37.2%

FY2026

Gross Margin

17.22% -0.6pp

FY2026

Operating Margin

-11.13% +18pp

FY2026

Diluted EPS

-$0.43 +49.4%

FY2026

Operating Cash Flow

-$1.55M +54.3%

FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2027 (G)	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenue	+14.4%	+24.2%	+23.2%	$30M – $33M	$31.53M^G	$19.09M	$19.1M	$21.04M	$15.68M	$10.67M	$9.92M	$6.8M	$4.04M	$3.15M	$3.92M	$3.91M	$3.65M	$2.52M	$2.15M	$2.25M
Cost of Revenue	+25.2%	+29.2%	+24.3%	—	$26.1M	$15.69M	$13.31M	$13.31M	$10.75M	$7.24M	$6.56M	$4.68M	$2.56M	$2.38M	$2.97M	$3.11M	$2.85M	$1.87M	$1.59M	$1.49M
Gross Profit	-11.1%	+9.6%	+19.1%	—	$5.43M	$3.4M	$5.8M	$7.73M	$4.93M	$3.43M	$3.36M	$2.12M	$1.48M	$773.72K	$942.02K	$798.27K	$800.8K	$654.43K	$557.41K	$752.12K
Gross Margin	—	—	—	—	17.22%	17.83%	30.35%	36.75%	31.43%	32.17%	33.89%	31.19%	36.7%	24.53%	24.05%	20.41%	21.93%	25.97%	25.9%	33.5%
Research & Development	+1.4%	+10.6%	+8.0%	—	$1.03M	$1.16M	$981.78K	$992.38K	$666.48K	$624.25K	$886.13K	$505.3K	$456.38K	$464.16K	$478.27K	$492.94K	$471.11K	$630.29K	$664.7K	$825.03K
Selling, General & Administrative	+2.3%	+16.3%	+17.7%	—	$7.91M	$7.8M	$7.54M	$7.38M	$5.61M	$3.71M	$3.9M	$2.1M	$1.37M	$1.31M	$1.55M	$1.55M	$1.5M	$1.26M	$1.19M	$958.51K
Amortization of Intangibles	—	—	—	—	—	—	—	—	—	—	—	—	$0	$0	$0	$0	$852	$0	$3099	$33.73K
Depreciation & Amortization	+9.8%	+13.7%	+26.9%	—	$279.28K	$212.44K	$212.38K	$210.74K	$190.22K	$146.8K	$112.22K	$38.55K	$27.22K	$33.66K	$25.86K	$21.27K	$20.02K	$20.97K	$23.37K	$57.61K
Total Operating Expenses	+2.2%	+15.6%	+16.2%	—	$8.94M	$8.96M	$8.52M	$8.37M	$6.44M	$4.34M	$4.79M	$2.74M	$1.83M	$1.78M	$2M	$2.01M	$1.96M	$1.89M	$1.84M	$1.74M
Operating Income	—	—	—	—	-$3.51M	-$5.55M	-$2.72M	-$638.55K	-$1.51M	-$905.58K	-$1.42M	-$612.54K	-$348.62K	-$1M	-$1.06M	-$1.21M	-$1.16M	-$1.23M	-$1.28M	-$991.91K
Operating Margin	—	—	—	—	-11.13%	-29.08%	-14.26%	-3.03%	-9.66%	-8.48%	-14.34%	-9%	-8.63%	-31.78%	-26.95%	-31.01%	-31.76%	-48.91%	-59.69%	-44.18%
EBITDA	—	—	—	—	-$3.23M	-$5.34M	-$2.51M	-$427.81K	-$1.32M	-$758.78K	-$1.31M	-$573.99K	-$321.4K	-$968.74K	-$1.03M	-$1.19M	-$1.14M	-$1.21M	-$1.26M	-$934.3K
Interest Expense	-12.2%	+94.6%	+77.8%	—	$148.13K	$227.02K	$225.11K	$218.93K	$155.66K	$5302	$1002	$1416	$1859	$3144	$469	$0	$0	$1408	$30.21K	$60K
Interest Income	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$76.15K	$535	$207
Pretax Income	—	—	—	—	-$3.62M	-$5.78M	-$2.95M	-$142.68K	-$927.46K	-$101.92K	-$1.42M	-$613.96K	-$350.48K	-$1.01M	-$1.03M	-$1.18M	-$1.16M	-$1.79M	$961.88K	—
Income Tax	+36.8%	+40.3%	+18.4%	—	$4958	$1936	$1936	$1936	$952	$912	$2165	$912	$912	$912	$912	$912	$912	$912	$912	$912
Net Income	—	—	—	—	-$3.63M	-$5.78M	-$2.95M	-$144.61K	-$928.42K	-$102.84K	-$1.43M	-$614.87K	-$351.39K	-$1.01M	-$1.03M	-$1.18M	-$1.16M	-$1.79M	$960.97K	-$1.05M
Net Margin	—	—	—	—	-11.51%	-30.28%	-15.45%	-0.69%	-5.92%	-0.96%	-14.37%	-9.04%	-8.7%	-31.9%	-26.42%	-30.13%	-31.79%	-70.95%	44.65%	-46.88%
Net Income Available to Common Stockholders	—	—	—	—	-$3.63M	-$5.78M	-$2.95M	-$144.61K	-$928.42K	-$102.84K	—	—	—	—	—	—	—	-$1.79M	$960.97K	-$1.05M
EPS (Basic) USD/shares	—	—	—	—	-$0.43	-$0.85	-$0.49	-$0.03	-$0.18	-$0.03	—	-$0.15	-$0.12	-$0.36	-$0.45	-$0.57	-$0.78	-$1.53	$2.49	-$3.18
EPS (Diluted) USD/shares	—	—	—	—	-$0.43	-$0.85	-$0.49	-$0.03	-$0.18	-$0.03	—	-$0.15	-$0.12	-$0.36	-$0.45	-$0.57	-$0.78	-$1.53	$2.34	-$3.18
Shares Outstanding (Basic Avg) shares	+14.6%	+14.0%	+13.6%	—	8.53M	6.79M	6.07M	5.67M	5.3M	4.43M	4.33M	3.83M	3.28M	2.78M	2.39M	2.09M	1.49M	1.17M	387.92K	331.59K
Shares Outstanding (Diluted Avg) shares	+14.6%	+14.0%	+13.6%	—	8.53M	6.79M	6.07M	5.67M	5.3M	4.43M	4.33M	3.83M	3.28M	2.78M	2.39M	2.09M	1.49M	1.17M	425.31K	331.59K

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Current finance lease liabilities	2026-06-30	USD 0	10-K filed 2026-09-28
Long-term debt, including current maturities	2026-06-30	USD 1,333,751	10-K filed 2026-09-28
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of long-term debt USD 577,898 Noncurrent debt carrying amount USD 711,305
Operating lease liabilities	2026-06-30	USD 2,772,076	10-K filed 2026-09-28
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 325,500 Noncurrent operating lease liabilities USD 2,446,576

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

1.34×

Peer median 2.31×

EV/EBIT

—

Peer median 16.49×

P/E (TTM)

—

Peer median 20.02×

Peer medians compare against the 16 similar-size Medical Instruments & Supplies companies (of 47 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021
Systems Manufacturing	$22,628,047	$8,290,225	$3,731,754	—	—	—
Ross Optical Industries	$4,910,538	$3,727,324	$4,132,541	—	—	—
Engineering Design Services	$3,473,640	$4,938,158	$8,519,130	$6,728,867	$5,371,483	—
Micro Optics Lab	$519,540	$2,135,562	$2,720,925	—	—	—
Engineering Design Services	—	—	—	—	—	$2,770,481
Medical Device	—	—	—	—	—	$2,153,214
Optical Components	—	—	—	—	—	$5,751,212
Medical Device Products and Assemblies	—	—	—	$3,791,794	$3,824,869	—
Optical Components	—	—	—	$10,523,806	$6,481,896	—

Key facts CIK 867840 CUSIP 740294400 Visit website Investor relations